XEPTM-716 Miniprotein

AssetAlso XEPTM-716 MiniproteinTM

Topical transforming growth factor-beta mimetic miniprotein that modulates epidermal morphometric features and cellular senescence.

Stage: Human trials
Modality: Protein or enzyme
Target: TGFB1; 1
Indication: 0
Trials: 1
Developer

Indications

1

Skin aging
Human trials, doi.org, Oct 1, 2026

In the full profile

Targets and what it contains2
Owner and partners1
Evidence for its targets2
Competitors2
Aging relevance2
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.